BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29589152)

  • 41. Neurogenetics in Child Neurology: Redefining a Discipline in the Twenty-first Century.
    Kaufmann WE
    Curr Neurol Neurosci Rep; 2016 Dec; 16(12):103. PubMed ID: 27815692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical exome sequencing in neurogenetic and neuropsychiatric disorders.
    Fogel BL; Lee H; Strom SP; Deignan JL; Nelson SF
    Ann N Y Acad Sci; 2016 Feb; 1366(1):49-60. PubMed ID: 26250888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical utility of genetic testing in pediatric drug-resistant epilepsy: a pilot study.
    Ream MA; Mikati MA
    Epilepsy Behav; 2014 Aug; 37():241-8. PubMed ID: 25108116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders.
    Lindy AS; Stosser MB; Butler E; Downtain-Pickersgill C; Shanmugham A; Retterer K; Brandt T; Richard G; McKnight DA
    Epilepsia; 2018 May; 59(5):1062-1071. PubMed ID: 29655203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic Yield of Intellectual Disability Gene Panels.
    Pekeles H; Accogli A; Boudrahem-Addour N; Russell L; Parente F; Srour M
    Pediatr Neurol; 2019 Mar; 92():32-36. PubMed ID: 30581057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usage of Genetic Panels in an Adult Epilepsy Clinic.
    Li J; Toffa DH; Lefèbvre M; Tétreault M; Cossette P; Samarut É; Nguyen DK
    Can J Neurol Sci; 2023 May; 50(3):411-417. PubMed ID: 35478072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy.
    Harris E; Topf A; Barresi R; Hudson J; Powell H; Tellez J; Hicks D; Porter A; Bertoli M; Evangelista T; Marini-Betollo C; Magnússon Ó; Lek M; MacArthur D; Bushby K; Lochmüller H; Straub V
    Orphanet J Rare Dis; 2017 Sep; 12(1):151. PubMed ID: 28877744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic analysis in neurology: the next 10 years.
    Pittman A; Hardy J
    JAMA Neurol; 2013 Jun; 70(6):696-702. PubMed ID: 23571731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test.
    Thevenon J; Duffourd Y; Masurel-Paulet A; Lefebvre M; Feillet F; El Chehadeh-Djebbar S; St-Onge J; Steinmetz A; Huet F; Chouchane M; Darmency-Stamboul V; Callier P; Thauvin-Robinet C; Faivre L; Rivière JB
    Clin Genet; 2016 Jun; 89(6):700-7. PubMed ID: 26757139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The benefits of a Neurogenetics clinic in an adult Academic Teaching Hospital.
    Olszewska DA; McVeigh T; Fallon EM; Pastores GM; Lynch T
    Ir J Med Sci; 2018 Nov; 187(4):1073-1076. PubMed ID: 29524103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Follow-up nationwide survey on predictive genetic testing for late-onset hereditary neurological diseases in Japan.
    Tanaka K; Sekijima Y; Yoshida K; Tamai M; Kosho T; Sakurai A; Wakui K; Ikeda S; Fukushima Y
    J Hum Genet; 2013 Aug; 58(8):560-3. PubMed ID: 23635952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes of prior authorization requests for genetic testing in outpatient pediatric genetics clinics.
    Smith HS; Franciskovich R; Lewis AM; Gerard A; Littlejohn RO; Nugent K; Rodriguez J; Streff H
    Genet Med; 2021 May; 23(5):950-955. PubMed ID: 33473204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High Degree of Genetic Heterogeneity for Hereditary Cerebellar Ataxias in Australia.
    Kang C; Liang C; Ahmad KE; Gu Y; Siow SF; Colebatch JG; Whyte S; Ng K; Cremer PD; Corbett AJ; Davis RL; Roscioli T; Cowley MJ; Park JS; Sue CM; Kumar KR
    Cerebellum; 2019 Feb; 18(1):137-146. PubMed ID: 30078120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genomics and Radiogenomics in Inherited Neurometabolic Disorders - A Practical Primer for Pediatricians.
    Sudhakar SV; Muthusamy K; Arunachal G; Shroff M
    Indian J Pediatr; 2019 Oct; 86(10):923-938. PubMed ID: 31197644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Approaches to the patient with neurogenetic disease.
    Bird TD
    Clin Lab Med; 2010 Dec; 30(4):785-93. PubMed ID: 20832652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploring neurologists' perspectives on the return of next generation sequencing results to their patients: a needed step in the development of guidelines.
    Hurlimann T; Jaitovich Groisman I; Godard B
    BMC Med Ethics; 2018 Sep; 19(1):81. PubMed ID: 30268121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical neurogenetics. A survey of the relationship of medical genetics to clinical neurology.
    Bird TD; Hall JG
    Neurology; 1977 Nov; 27(11):1057-60. PubMed ID: 144871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ontological phenotype standards for neurogenetics.
    Köhler S; Doelken SC; Rath A; Aymé S; Robinson PN
    Hum Mutat; 2012 Sep; 33(9):1333-9. PubMed ID: 22573485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Current status of predictive genetic testing in neurological diseases - from the stand point of genetic specialist].
    Yoshida M
    Rinsho Shinkeigaku; 2013; 53(11):1006-8. PubMed ID: 24291861
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalent.
    Powis Z; Espenschied CR; LaDuca H; Hagman KD; Paudyal T; Li S; Inaba H; Mauer A; Nathanson KL; Knost J; Chao EC; Tang S
    Cancer Genet; 2018 Aug; 224-225():12-20. PubMed ID: 29778231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.